Search - tctmd.com

Displaying 361 - 380 of 448

Sort: Relevancy | Date

Presentation TCT 2015

Bioresorbable Scaffolds in a Bifurcation During Primary PCI

Presenter: Mirvat Alasnag, Habib Gamra, Abdullah Shehab

October 11, 2015

Presentation TCT 2015

Two US PAD Trials That May Well Change Your Practice: Updates on the ENDOMAX and LIBERTY-360 Studies

Presenter: Hans Krankenberg, Lindsay S. Machan, Herbert D. Aronow

October 11, 2015

Presentation TCT 2015

STEMI With Left Main Occlusion and Cardiac Arrest

Presenter: Mirvat Alasnag, Habib Gamra, Abdullah Shehab, Mehdi MS Slim

October 11, 2015

Presentation TCT 2015

Management Strategies for SFA/Popliteal In-Stent Restenosis

Presenter: Hans Krankenberg, Lindsay S. Machan

October 11, 2015

Presentation TCT 2015

Primary PCI for STEMI in a 19-Year-Old Pregnant Patient With Cardiogenic Shock

Presenter: Mirvat Alasnag, Habib Gamra, Abdullah Shehab, Kais BATTIKH

October 11, 2015

Presentation TCT 2015

Embolic Protection in Lower-Extremity Intervention: Where Does It Make the Most Sense?

Presenter: Hans Krankenberg, Lindsay S. Machan, Venkatesh Ramaiah

October 11, 2015

Presentation TCT 2015

Use of a Reentry Device for a Coronary CTO With Bioresorbable Scaffolds

Presenter: Mirvat Alasnag, Habib Gamra, Abdullah Shehab, Waqar H. Ahmed

October 11, 2015

Presentation TCT 2015

Access Alternatives in Long SFA Disease

Presenter: Hans Krankenberg, Lindsay S. Machan, Andrej Schmidt

October 11, 2015

Presentation TCT 2015

Use of a Novel Reentry Device for a Peripheral CTO

Presenter: Mirvat Alasnag, Habib Gamra, Abdullah Shehab

October 11, 2015

Presentation TCT 2015

OCT-Guided CTO Crossing and Atherectomy: Are There Advantages of Image-Guided Intervention?

Presenter: Hans Krankenberg, Lindsay S. Machan, Roger Gammon

October 11, 2015

Presentation TCT 2015

Has the TASC Classification Scheme Been Made Obsolete by Todays Antiproliferative Therapeutics?

Presenter: Hans Krankenberg, Lindsay S. Machan

October 11, 2015

Presentation TCT 2015

Lithoplasty in Calcified SFA Lesions: Update on Outcomes and Future Trials

Presenter: Prakash Krishnan, Mahmood K. Razavi, Todd J. Brinton

October 11, 2015

Presentation TCT 2015

Debulking in the Antiproliferative Era: Which Patient Is Most Likely to Benefit?

Presenter: Prakash Krishnan, Mahmood K. Razavi, Lawrence A. Garcia

October 11, 2015

Presentation TCT 2015

A Master Class in Atherectomy: Choices, Strategies, and Execution

Presenter: Prakash Krishnan, Mahmood K. Razavi

October 11, 2015

Presentation TCT 2015

Biomimetic Stents: Rationale and Current Clinical Results

Presenter: Prakash Krishnan, Mahmood K. Razavi, Eric J. Dippel

October 11, 2015

Presentation TCT 2015

Adventitial Injection Therapy for Restenosis: Rationale and Clinical Results to Date

Presenter: Prakash Krishnan, Mahmood K. Razavi, Christopher D. Owens

October 11, 2015

Presentation TCT 2015

Update on Bioresorbable Scaffolds for PAD

Presenter: Prakash Krishnan, Mahmood K. Razavi

October 11, 2015

Presentation TCT 2015

Evolving Endovascular Treatment Strategies for Femoral-Popliteal Disease in a DES and DCB World

Presenter: Gary M. Ansel, Michael R. Jaff

October 11, 2015

Presentation TCT 2015

Review and Perspectives of the Global Registry Data for Antiproliferative Therapies

Presenter: Gary M. Ansel, Michael R. Jaff, John R. Laird Jr

October 11, 2015

Presentation TCT 2015

Review of Multicenter, Randomized Outcomes Data of Antiproliferative Therapies: Zilver PTX, LEVANT II, In.PACT SFA, and DEFINITIVE AR

Presenter: Gary M. Ansel, Michael R. Jaff, Ravish Sachar

October 11, 2015

Advertisement

Bioresorbable Scaffolds in a Bifurcation During Primary PCI

Two US PAD Trials That May Well Change Your Practice: Updates on the ENDOMAX and LIBERTY-360 Studies

STEMI With Left Main Occlusion and Cardiac Arrest

Management Strategies for SFA/Popliteal In-Stent Restenosis

Primary PCI for STEMI in a 19-Year-Old Pregnant Patient With Cardiogenic Shock

Embolic Protection in Lower-Extremity Intervention: Where Does It Make the Most Sense?

Use of a Reentry Device for a Coronary CTO With Bioresorbable Scaffolds

Access Alternatives in Long SFA Disease

Use of a Novel Reentry Device for a Peripheral CTO

OCT-Guided CTO Crossing and Atherectomy: Are There Advantages of Image-Guided Intervention?

Has the TASC Classification Scheme Been Made Obsolete by Todays Antiproliferative Therapeutics?

Lithoplasty in Calcified SFA Lesions: Update on Outcomes and Future Trials

Debulking in the Antiproliferative Era: Which Patient Is Most Likely to Benefit?

A Master Class in Atherectomy: Choices, Strategies, and Execution

Biomimetic Stents: Rationale and Current Clinical Results

Adventitial Injection Therapy for Restenosis: Rationale and Clinical Results to Date

Update on Bioresorbable Scaffolds for PAD

Evolving Endovascular Treatment Strategies for Femoral-Popliteal Disease in a DES and DCB World

Review and Perspectives of the Global Registry Data for Antiproliferative Therapies

Review of Multicenter, Randomized Outcomes Data of Antiproliferative Therapies: Zilver PTX, LEVANT II, In.PACT SFA, and DEFINITIVE AR

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content